The role of zinc sulfate in acute bronchiolitis in patients aged 2 months to 23 months old

Effect of Zinc Sulfate on clinical symptoms of acute bronchiolitis in children less than 2 years old

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201011065114N1

Enrollment

Registered

2010-12-23

Start date

2008-01-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute bronchiolitis. Acute bronchiolitis

Interventions

Intervention 1: Syrup of zinc sulfate 1% (1CC per kg) for children below 1 year old and 20 mg elemental zinc for older than 1 year old in case group were administered during hospitalization. Intervent

Treatment - Drugs

Syrup of zinc sulfate 1% (1CC per kg) for children below 1 year old and 20 mg elemental zinc for older than 1 year old in case group were administered during hospitalization

The control group was taken placebo. The bottles were similar in size and shape for both case and control groups.

Eligibility

Sex/Gender

All

Age

1 Years to 2 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age 2 months to 23 months, first attack of wheezing. Exclusion criteria: Any history of previous wheezing attack(s), congenital heart disease, severe malnutrition, any history of taking zinc sulfate last month and pneumonia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical manifestations. Timepoint: every day. Method of measurement: Physical exam.;Recovery. Timepoint: Daily. Method of measurement: Inspection.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Farhad Heydarian

Mashhad Unuversity of Medical Sciences

heydarianf@mums.ac.ir; haydarianf@yahoo.com; farhad.heydarian@gmail.com+98 51 1801 2469

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026